Form 4: Moderna CFO James Mock Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Moderna, James Mock, reports the acquisition and disposal of company stock and restricted stock units.
Summary
- On February 28, 2024, James Mock, the CFO of Moderna, acquired 4,947 shares of common stock and disposed of 1,315 shares related to the vesting of restricted stock units (RSUs).
- On February 29, 2024, Mock disposed of 647 shares of common stock at a price of $94.572 per share to cover tax withholding obligations.
- Following these transactions, Mock directly owns 4,300 shares of Moderna common stock and 3,945 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, which has a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel and their holdings in the company.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction involving acquisition and disposal of common stock and vesting of restricted stock units. |
| 02/29/2024 | Date of transaction involving the disposal of common stock to cover tax withholding obligations. |
| 03/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.